MedTrace Logo

Atrial Functional Mitral Regurgitation Response In Mitral Loop Cerclage Annuloplasty (AFRICA Study)

NCT03453853 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-04-26

No results posted yet for this study

Summary

To evaluate second stage safety and feasibility of Mitral Loop Cerclage(MLC) Annuloplasty with CSTV for repair of functional mitral regurgitation.

Conditions

Interventions

DEVICE

Mitral Loop Cerclage Annuloplasty

Atrial Functional mitral regurgitation Response In mitral loop Cerclage Annuloplasty

Sponsors & Collaborators

  • Tau-MEDICAL Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yong-Hyun Park, MD, PhD · Pusan National University Yangsan Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-02
Primary Completion
2018-11-17
Completion
2021-04-03

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03453853 on ClinicalTrials.gov